A detailed history of Spire Wealth Management transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 297 shares of ANIK stock, worth $2,714. This represents 0.0% of its overall portfolio holdings.

Number of Shares
297
Previous 511 41.88%
Holding current value
$2,714
Previous $7,000 57.14%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025

SELL
$10.58 - $15.05 $2,264 - $3,220
-214 Reduced 41.88%
297 $3,000
Q1 2025

Apr 23, 2025

BUY
$15.03 - $17.97 $7,680 - $9,182
511 New
511 $7,000
Q2 2021

Jul 26, 2021

SELL
$39.42 - $48.08 $17,620 - $21,491
-447 Closed
0 $0
Q1 2021

May 21, 2021

BUY
$32.49 - $45.96 $14,523 - $20,544
447 New
447 $16,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $133M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.